Correlation Between Biofrontera Warrants and XORTX Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biofrontera Warrants and XORTX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofrontera Warrants and XORTX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biofrontera Warrants and XORTX Therapeutics, you can compare the effects of market volatilities on Biofrontera Warrants and XORTX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofrontera Warrants with a short position of XORTX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofrontera Warrants and XORTX Therapeutics.

Diversification Opportunities for Biofrontera Warrants and XORTX Therapeutics

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Biofrontera and XORTX is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Biofrontera Warrants and XORTX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XORTX Therapeutics and Biofrontera Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofrontera Warrants are associated (or correlated) with XORTX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XORTX Therapeutics has no effect on the direction of Biofrontera Warrants i.e., Biofrontera Warrants and XORTX Therapeutics go up and down completely randomly.

Pair Corralation between Biofrontera Warrants and XORTX Therapeutics

Assuming the 90 days horizon Biofrontera Warrants is expected to generate 7.17 times more return on investment than XORTX Therapeutics. However, Biofrontera Warrants is 7.17 times more volatile than XORTX Therapeutics. It trades about 0.03 of its potential returns per unit of risk. XORTX Therapeutics is currently generating about -0.18 per unit of risk. If you would invest  19.00  in Biofrontera Warrants on August 31, 2024 and sell it today you would lose (11.11) from holding Biofrontera Warrants or give up 58.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy90.91%
ValuesDaily Returns

Biofrontera Warrants  vs.  XORTX Therapeutics

 Performance 
       Timeline  
Biofrontera Warrants 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Biofrontera Warrants are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady forward indicators, Biofrontera Warrants showed solid returns over the last few months and may actually be approaching a breakup point.
XORTX Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days XORTX Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Biofrontera Warrants and XORTX Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biofrontera Warrants and XORTX Therapeutics

The main advantage of trading using opposite Biofrontera Warrants and XORTX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofrontera Warrants position performs unexpectedly, XORTX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XORTX Therapeutics will offset losses from the drop in XORTX Therapeutics' long position.
The idea behind Biofrontera Warrants and XORTX Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Fundamental Analysis
View fundamental data based on most recent published financial statements
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon